The federal government will face a class action on behalf of disabled individuals age 65 and over who have been excluded from the National Disability Insurance Scheme.
The consumer regulator has taken a page from ASIC, warning it will take action against businesses that make unsupported environmental or sustainability claims.
Opal Tower structural engineer WSP has been ordered to produce all professional indemnity policies covering its work on the defective building in a lawsuit against insurers for builder Icon, despite arguing for the “commercial sensitivity” of the information.
Two receivers for unlicensed investment scheme A One Multi Services have lost their bid to have 85 per cent of their future remuneration paid out immediately, with a judge agreeing with the corporate regulator that the receivers should not have âwhat are in effect trust fundsâ.
A former Greenwoods & Herbert Smith Freehills partner wants the Full Court to decide whether whistleblower protections apply retrospectively in a $13 million suit alleging he was sacked for complaining about the tax avoidance strategy of construction giant Lendlease.
A judge has signed off on a $1.55 million settlement to resolve two underpayments class actions against supermarket chain Romeoâs, but has reduced the pay out to the law firm running the cases by 25 per cent, saying the firm had “no legal entitlement” to the fees.
A judge has signed off on a $7.2 million penalty against Dixon Advisory after the company admitted to ASIC allegations that its advisors failed to act in its clients’ best interests by recommending they invest in a risky US-based real estate investment fund.
Insurer for cladding manufacturer Fairview Architectural, Vero Insurance, will argue a $190 million policy does not cover claims in a class action alleging combustible cladding caused losses for property owners, a court has heard.
The Australian unit of Mylan is challenging the ATO’s rejection of a $48 million deduction for 2020 in the generic drug company’s latest spat with the tax office over interest on loans to fund its $1.2 billion acquisition of generic drug maker Alphapharm.
A test case stemming from the 2019 ‘sports rorts’ scandal will not make it to trial, after a club denied funding from a $100 million grants program discontinued its lawsuit against the Australian government agency responsible for community sports.